AAAAAA

   
Results: 1-21 |
Results: 21
Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients
Authors: Di Paolo, A Danesi, R Falcone, A Cionini, L Vannozzi, F Masi, G Allegrini, G Mini, E Bocci, G Conte, PF Del Tacca, M
Citation: A. Di Paolo et al., Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients, ANN ONCOL, 12(9), 2001, pp. 1301-1306
Repetita iuvant - INTACC (Intergruppo Italiano Terapia Adiuvante Carcinomadel Colon)
Authors: Di Costanzo, F Gasperoni, S Falcone, A Dogliotti, L Frassinetti, L Bruzzi, P Rosso, R
Citation: F. Di Costanzo et al., Repetita iuvant - INTACC (Intergruppo Italiano Terapia Adiuvante Carcinomadel Colon), ANN ONCOL, 12(9), 2001, pp. 1331-1331
Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients
Authors: Falcone, A Di Paolo, A Masi, G Allegrini, G Danesi, R Lencioni, M Pfanner, E Comis, S Del Tacca, M Conte, P
Citation: A. Falcone et al., Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients, J CL ONCOL, 19(15), 2001, pp. 3456-3462
Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone
Authors: Musto, P Sanpaolo, G D'Arena, G Scalzulli, PR Matera, R Falcone, A Bodenizza, C Perla, G Carotenuto, M
Citation: P. Musto et al., Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone, HAEMATOLOG, 86(1), 2001, pp. 44-51
5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: A randomized phase II study in metastatic colorectal cancer
Authors: Falcone, A Allegrini, G Masi, G Lencioni, M Pfanner, E Brunetti, I Danesi, R Bocci, G Del Tacca, M Conte, P
Citation: A. Falcone et al., 5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: A randomized phase II study in metastatic colorectal cancer, ONCOL-BASEL, 61(1), 2001, pp. 28-35
A survey of the northern sky for TeV point sources
Authors: Wang, K Atkins, R Benbow, W Berley, D Chen, ML Coyne, DG Dingus, BL Dorfan, DE Ellsworth, RW Falcone, A Fleysher, L Fleysher, R Gisler, G Goodman, JA Haines, TJ Hoffman, CM Hugenberger, S Kelley, LA Leonor, I McConnell, M McCullough, JF McEnery, JE Miller, RS Mincer, AI Morales, MF Nemethy, P Ryan, JM Samuelson, FW Shen, B Shoup, A Sinnis, G Smith, AJ Sullivan, GW Tumer, OT Wascko, O Westerhoff, S Williams, DA Yang, T Yodh, GB
Citation: K. Wang et al., A survey of the northern sky for TeV point sources, ASTROPHYS J, 558(2), 2001, pp. 477-481
Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients
Authors: Bocci, G Danesi, R Di Paolo, A Innocenti, F Allegrini, G Falcone, A Melosi, A Battistoni, M Barsanti, G Conte, PF Del Tacca, M
Citation: G. Bocci et al., Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients, CLIN CANC R, 6(8), 2000, pp. 3032-3037
Milagrito, a TeV air-shower array
Authors: Atkins, R Benbow, W Berley, D Chen, ML Coyne, DG Delay, RS Dingus, BL Dorfan, DE Ellsworth, RW Espinoza, C Evans, D Falcone, A Fleysher, L Fleysher, R Gisler, G Goodman, JA Haines, TJ Hoffman, CM Hugenberger, S Kelley, LA Klein, S Leonor, I Macri, J McConnell, M McCullough, JF McEnery, JE Miller, RS Mincer, AI Morales, MF Murray, MM Nemethy, P Paliaga, G Ryan, JM Schneider, M Shen, B Shoup, A Sinnis, G Smith, AJ Sullivan, GW Thompson, TN Tumer, OT Wang, K Wascko, MO Westerhoff, S Williams, DA Yang, T Yodh, GB
Citation: R. Atkins et al., Milagrito, a TeV air-shower array, NUCL INST A, 449(3), 2000, pp. 478-499
Oral doxifluridine in advanced hepatocellular carcinoma: A phase II study
Authors: Lencioni, M Falcone, A Allegrini, G Pfanner, E Masi, G Brunetti, I Di Marsico, R Fontana, E Orlandini, C Stampino, CG Bartolozzi, C Conte, PF
Citation: M. Lencioni et al., Oral doxifluridine in advanced hepatocellular carcinoma: A phase II study, ONCOL-BASEL, 59(3), 2000, pp. 204-209
Evidence for TeV emission from GRB 970417a
Authors: Atkins, R Benbow, W Berley, D Chen, ML Coyne, DG Dingus, BL Dorfan, DE Ellsworth, RW Evans, D Falcone, A Fleysher, L Fleysher, R Gisler, G Goodman, JA Haines, TJ Hoffman, CM Hugenberger, S Kelley, LA Leonor, I McConnell, M McCullough, JF McEnery, JE Miller, RS Mincer, AI Morales, MF Nemethy, P Ryan, JM Shen, B Shoup, A Sinnis, C Smith, AJ Sullivan, GW Tumer, T Wang, K Wascko, MO Westerhoff, S Williams, DA Yang, T Yodh, GB
Citation: R. Atkins et al., Evidence for TeV emission from GRB 970417a, ASTROPHYS J, 533(2), 2000, pp. L119-L122
Effects of cyclosporin A and dinactin on T-cell proliferation, interleukin-5 production, and murine pulmonary inflammation
Authors: Umland, SP Shah, H Jakway, JP Shortall, J Razac, S Garlisi, CG Falcone, A Kung, TT Stelts, D Hegde, V Patel, M Billah, MM Egan, RW
Citation: Sp. Umland et al., Effects of cyclosporin A and dinactin on T-cell proliferation, interleukin-5 production, and murine pulmonary inflammation, AM J RESP C, 20(3), 1999, pp. 481-492
Effects of chronic anti-interleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation
Authors: Garlisi, CG Kung, TT Wang, P Minnicozzi, M Umland, SP Chapman, RW Stelts, D Crawley, Y Falcone, A Myers, JG Jones, H Billah, MM Kreutner, W Egan, RW
Citation: Cg. Garlisi et al., Effects of chronic anti-interleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation, AM J RESP C, 20(2), 1999, pp. 248-255
Rationale for treatment of metastatic disease of the liver
Authors: Conte, PF Falcone, A Pfanner, E
Citation: Pf. Conte et al., Rationale for treatment of metastatic disease of the liver, MED RADIOL, 1999, pp. 335-338
Milagro as a solar observatory
Authors: Falcone, A Ryan, J
Citation: A. Falcone et J. Ryan, Milagro as a solar observatory, ASTROPART P, 11(1-2), 1999, pp. 283-285
Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study
Authors: Falcone, A Allegrini, G Lencioni, M Pfanner, E Brunetti, I Cianci, C Galli, C Masi, G Antonuzzo, A Conte, P
Citation: A. Falcone et al., Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study, CANC CHEMOT, 44(2), 1999, pp. 159-163
Intrahepatic chemotherapy with floxuridine, leucovorin and dexamethasone in continuous infusion and mitomycin-C bolus in unresectable hepatic metastases from colorectal cancer: A phase II study
Authors: Bertuccelli, M Falcone, A Campoccia, S Conti, M Brunetti, I Caramella, D Giulianotti, PC Mosca, F Bartolozzi, C Conte, P
Citation: M. Bertuccelli et al., Intrahepatic chemotherapy with floxuridine, leucovorin and dexamethasone in continuous infusion and mitomycin-C bolus in unresectable hepatic metastases from colorectal cancer: A phase II study, TUMORI, 85(6), 1999, pp. 473-477
Infusions of fluorouracil and leucovorin: Effects of the timing and semi-intermittency of drug delivery
Authors: Falcone, A Allegrini, G Antonuzzo, A Brunetti, I Pfanner, E Lencioni, M Masi, G Danesi, R Del Tacca, M Conte, P
Citation: A. Falcone et al., Infusions of fluorouracil and leucovorin: Effects of the timing and semi-intermittency of drug delivery, ONCOL-BASEL, 57(3), 1999, pp. 195-201
Suramin in combination with weekly epirubicin for patients with advanced hormone-refractory prostate carcinoma
Authors: Falcone, A Antonuzzo, A Danesi, R Allegrini, G Monica, L Pfanner, E Masi, G Ricci, S Del Tacca, M Conte, P
Citation: A. Falcone et al., Suramin in combination with weekly epirubicin for patients with advanced hormone-refractory prostate carcinoma, CANCER, 86(3), 1999, pp. 470-476
TeV observations of Markarian 501 with the Milagrito water Cerenkov detector
Authors: Atkins, R Benbow, W Berley, D Chen, ML Coyne, DG Delay, RS Dingus, BL Dorfan, DE Ellsworth, RW Espinoza, C Evans, D Falcone, A Fleysher, L Fleysher, R Gisler, G Goodman, JA Haines, TJ Hoffman, CM Hugenberger, S Kelley, LA Leonor, I McConnell, M McCullough, JF McEnery, JE Miller, RS Mincer, AI Morales, MF Murray, MM Nemethy, P Ryan, JM Schneider, M Shen, B Shoup, A Sinnis, C Smith, AJ Sullivan, GW Thompson, TN Tumer, T Wang, K Wascko, MO Westerhoff, S Williams, DA Yang, T Yodh, GB
Citation: R. Atkins et al., TeV observations of Markarian 501 with the Milagrito water Cerenkov detector, ASTROPHYS J, 525(1), 1999, pp. L25-L28
Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy
Authors: Falcone, A Pfanner, E Brunetti, I Allegrini, G Lencioni, M Galli, C Masi, G Danesi, D Antonuzzo, A Del Tacca, M Conte, PF
Citation: A. Falcone et al., Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy, TUMORI, 84(6), 1998, pp. 666-668
Treatment of patients with colorectal cancer - Introduction
Authors: Aschele, C Casaretti, R Cascinu, S Cavaliere, R Colucci, G Comandone, A Comella, G Cortesi, E Cosimelli, M De Conno, F Di Costanzo, F Falcone, A Fosser, V Frassineti, L Gardani, G Goffredo, F Ruggieri, FG Labianca, R Maiello, E Nitti, D Pozzo, C Pugliese, P Rinieri, MT Roila, F Severini, A Sobrero, A Spinelli, P Tamburini, M Torri, V Terzoli, E Zaniboni, A
Citation: C. Aschele et al., Treatment of patients with colorectal cancer - Introduction, TUMORI, 84(4), 1998, pp. S1
Risultati: 1-21 |